Related Experiment Video
Updated: Jun 3, 2026

Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
K(+) channels as therapeutic targets in oncology
1Department of Molecular Biology of Neuronal Signals, Max-Planck Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075 Göttingen, Germany. ws@em.mpg.de
Abstract:
Ion channels are involved in a variety of tumors. In particular, potassium channels are expressed abnormally in many cancer types, where their pharmacologic manipulation impairs tumor progression. Since this group of molecules has been successfully targeted for decades in other therapeutic areas, there is a significant body of knowledge on the pharmacology of potassium channels. Several groups of potassium channels with defined molecular identities have been proposed as candidates for therapeutic intervention. The strategies put forward range from classical small molecule blockade to gene therapy approaches, and include the use of potassium channels as targets for adjuvant therapy. We will discuss the reasons for these proposals and explore possible future developments.
Insights
Potassium channels are abnormally expressed in many cancers, and targeting them can impair tumor progression. Research explores various strategies, including small molecules and gene therapy, for therapeutic intervention in cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Ion channels play a role in various tumors.
- Abnormal potassium channel expression is observed in numerous cancer types.
- Pharmacological targeting of potassium channels can impede tumor progression.
Purpose of the Study:
- To review the role of potassium channels in cancer.
- To discuss the therapeutic potential of targeting potassium channels in oncology.
- To explore future developments in potassium channel-targeted cancer therapies.
Main Methods:
- Review of existing literature on potassium channels in cancer.
- Analysis of pharmacological strategies for potassium channel manipulation.
- Exploration of gene therapy and adjuvant therapy approaches.
Main Results:
- Potassium channels are viable therapeutic targets in cancer.
- A significant body of knowledge exists regarding potassium channel pharmacology.
- Various therapeutic strategies are proposed, including small molecule inhibitors and gene therapy.
Conclusions:
- Potassium channels represent promising targets for cancer therapy.
- Further research into potassium channel modulation could lead to novel cancer treatments.
- The development of targeted therapies holds potential for improving cancer patient outcomes.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Inhibition of Cdk Activity
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

